trending Market Intelligence /marketintelligence/en/news-insights/trending/PFA72KqwN6N49ZN2S9_MWQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: Aetna sets up $200M medical benefit claims ratio-linked cat bond

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Fintech Funding Flows To Insurtech In February

Report: Aetna sets up $200M medical benefit claims ratio-linked cat bond

Aetna Inc. established a special purpose vehicle for a $200 million insurance-linked securities transaction, Artemis reported.

Cayman Islands-based Vitality Re XI Ltd. will issue two tranches of series 2020 notes. The $140 million class A tranche will provide coverage for losses above a medical benefit claims ratio of 102%, equivalent to a $1.02 billion loss level and an expected loss of less than 0.01%. The notes will be offered to investors with a price guidance range of 1.75% to 2.25%.

The $60 million class B tranche will cover Aetna for losses above a medical benefit claims ratio of 96%, equivalent to a $960 million loss level and an expected loss of 0.04%. The notes are being marketed with price guidance of between 2% and 2.75%, according to the report.

Goldman Sachs is the sole book runner and co-structuring agent for the issuance, while Munich Re is acting as co-manager and co-structuring agent.

As part of the transaction, Aetna Life Insurance Co. will enter into a quota share reinsurance agreement with Vermont captive Health Re Inc. Health Re will then enter into two excess of loss reinsurance agreements with the special purpose vehicle.